Personalized medicine for cancer therapy: Lessons learned from tumor-associated antigens

Antibody signatures may become sophisticated screening tools for early diagnosis and the development of personalized anticancer treatments. We used biopanning to enrich the immune response of head and neck squamous cell carcinoma (HNSCC) patients. This method revealed a HNSCC-specific antibody signa...

Descripción completa

Detalles Bibliográficos
Autores principales: Scanlon, Christina Springstead, D’Silva, Nisha J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654574/
https://www.ncbi.nlm.nih.gov/pubmed/23734304
http://dx.doi.org/10.4161/onci.23433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654574/
https://www.ncbi.nlm.nih.gov/pubmed/23734304
http://dx.doi.org/10.4161/onci.23433

Ejemplares similares